journal article·2012-03-27

Poly-l-lysine Functionalized Large Pore Cubic Mesostructured Silica Nanoparticles as Biocompatible Carriers for Gene Delivery

Sandy B. Hartono, Wenyi Gu, Freddy Kleitz, Jian Liu, Lizhong He, Anton P. J. Middelberg, Chengzhong Yu, Gao Qing (Max) Lu, Shi Zhang Qiao

ACS Nano· Volume 6· Issue 3
Publisher page

Abstract

Large pore mesoporous silica nanoparticles (LP-MSNs) functionalized with poly-L-lysine (PLL) were designed as a new carrier material for gene delivery applications. The synthesized LP-MSNs are 100-200 nm in diameter and are composed of cage-like pores organized in a cubic mesostructure. The size of the cavities is about 28 nm with an entrance size of 13.4 nm. Successful grafting of PLL onto the silica surface through covalent immobilization was confirmed by X-ray photoelectron spectroscopy, solid-state (13)C magic-angle spinning nuclear magnetic resonance, Fourier transformed infrared, and thermogravimetric analysis. As a result of the particle modification with PLL, a significant increase of the nanoparticle binding capacity for oligo-DNAs was observed compared to the native unmodified silica particles. Consequently, PLL-functionalized nanoparticles exhibited a strong ability to deliver oligo DNA-Cy3 (a model for siRNA) to Hela cells. Furthermore, PLL-functionalized nanoparticles were proven to be superior as gene carriers compared to amino-functionalized nanoparticles and the native nanoparticles. The system was tested to deliver functional siRNA against minibrain-related kinase and polo-like kinase 1 in osteosarcoma cancer cells. Here, the functionalized particles demonstrated great potential for efficient gene transfer into cancer cells as a decrease of the cellular viability of the osteosarcoma cancer cells was induced. Moreover, the PLL-modified silica nanoparticles also exhibit a high biocompatibility, with low cytotoxicity observed up to 100 μg/mL.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Advanced biosensing and bioanalysis techniques · RNA Interference and Gene Delivery · DNA and Nucleic Acid Chemistry

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

ARC Centre of Excellence for Functional Nanomaterials, Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, QLD 4072, Australia

Department of Chemistry and Centre de Recherche sur les Matériaux Avancés (CERMA), Université Laval, Quebec City, G1 V 0A6, QC, Canada

Centre for Biomolecular Engineering, Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, QLD 4072, Australia

School of Chemical Engineering, The University of Adelaide, SA5005, Australia

References (59)

Show source-provided references
1. Ozpolat B. · J. Intern. Med. · 2009 · 267 · 4410.1111/j.1365-2796.2009.02191.x ↗
2. Sibley C. R. · Mol. Ther. · 2010 · 18 · 46610.1038/mt.2009.306 ↗
3. Reischl D. · Nanomedicine · 2009 · 5 · 810.1016/j.nano.2008.06.001 ↗
4. Pathak A. · Biotechnol. J. · 2009 · 4 · 155910.1002/biot.200900161 ↗
5. Rosenholm J. M. · Small · 2010 · 6 · 123410.1002/smll.200902355 ↗
6. Mamaeva V. · Mol. Ther. · 2011 · 19 · 153810.1038/mt.2011.105 ↗
7. Xia T. · ACS Nano · 2009 · 3 · 327310.1021/nn900918w ↗
8. Vallet-Regi M. · Angew. Chem., Int. Ed. · 2007 · 46 · 754810.1002/anie.200604488 ↗
9. Hartono S. B. · J. Phys. Chem. C · 2010 · 114 · 835310.1021/jp102368s ↗
10. Kneuer C. · Int. J. Pharm. · 2000 · 196 · 25710.1016/S0378-5173(99)00435-4 ↗
11. Meng H. · ACS Nano · 2010 · 4 · 453910.1021/nn100690m ↗
12. Hom C. · Small · 2010 · 6 · 118510.1002/smll.200901966 ↗
13. Li X. · Langmuir · 2011 · 27 · 609910.1021/la104653s ↗
14. Solberg S. M. · J. Phys. Chem. B · 2006 · 110 · 1526110.1021/jp061691+ ↗
15. Gao F. · J. Phys. Chem. B · 2009 · 113 · 179610.1021/jp807956r ↗
16. Kim M.-H. · ACS Nano · 2011 · 5 · 356810.1021/nn103130q ↗
17. Tanaka T. · Cancer Res. · 2010 · 70 · 368710.1158/0008-5472.CAN-09-3931 ↗
18. Moghimi S. M. · FASEB J. · 2005 · 19 · 31110.1096/fj.04-2747rev ↗
19. Bhattarai S. R. · Pharm. Res. · 2010 · 27 · 255610.1007/s11095-010-0245-0 ↗
20. Wolfert M. A. · Bioconjugate Chem. · 1999 · 10 · 99310.1021/bc990025r ↗
21. Liu G. · J. Biol. Chem. · 2001 · 276 · 3437910.1074/jbc.M105250200 ↗
22. Chen A. M. · Small · 2009 · 5 · 267310.1002/smll.200900621 ↗
23. Zhu S. · Chin. Sci. Bull. · 2002 · 47 · 65410.1360/02tb9149 ↗
24. Zhu S.-G. · Biotechnol. Appl. Biochem. · 2004 · 39 · 17910.1042/BA20030077 ↗
25. Li Z. · J. Nanosci. Nanotechnol. · 2005 · 5 · 119910.1166/jnn.2005.220 ↗
26. Lunn J. D. · Chem. Mater. · 2009 · 21 · 363810.1021/cm901025n ↗
27. Kar M. · J. Mater. Chem. · 2011 · 21 · 669010.1039/c0jm04589f ↗
28. Yiu H. H. P. · Adv. Funct. Mater. · 2010 · 20 · 159910.1002/adfm.200902117 ↗
29. Fan J. · J. Am. Chem. Soc. · 2005 · 127 · 1079410.1021/ja052619c ↗
30. Lukens W. W. · Langmuir · 1999 · 15 · 540310.1021/la990209u ↗
31. Fan J. · Angew. Chem., Int. Ed. · 2003 · 42 · 314610.1002/anie.200351027 ↗
32. Schacht S. · Microporous Mesoporous Mater. · 1998 · 22 · 48510.1016/S1387-1811(98)00086-9 ↗
33. Pauwels B. · Adv. Mater. · 2001 · 13 · 131710.1002/1521-4095(200109)13:17<1317::AID-ADMA1317>3.0.CO;2-5 ↗
34. Han Y. · Angew. Chem., Int. Ed. · 2005 · 44 · 28810.1002/anie.200460892 ↗
35. Suteewong T. · J. Am. Chem. Soc. · 2011 · 133 · 17210.1021/ja1061664 ↗
36. Roy I. · Proc. Natl. Acad. Sci. U.S.A. · 2005 · 102 · 27910.1073/pnas.0408039101 ↗
37. Sayari A. · Chem. Mater. · 2001 · 13 · 315110.1021/cm011039l ↗
38. Sales J. A. A. · Polyhedron · 2002 · 21 · 264710.1016/S0277-5387(02)01253-6 ↗
39. Luten J. · J. Controlled Release · 2008 · 126 · 9710.1016/j.jconrel.2007.10.028 ↗
40. Symonds P. · FEBS Lett. · 2005 · 579 · 619110.1016/j.febslet.2005.09.092 ↗
41. Wahab M. A. · Chem. Mater. · 2005 · 17 · 216510.1021/cm0480059 ↗
42. Mirau P. A. · Chem. Mater. · 2008 · 20 · 221810.1021/cm702283u ↗
43. Fernandez V. L. · J. Am. Chem. Soc. · 1992 · 114 · 963410.1021/ja00050a051 ↗
44. Zhang Q. · Chin. Sci. Bull. · 2009 · 54 · 262010.1007/s11434-009-0210-7 ↗
45. Kar M. · Langmuir · 2010 · 26 · 577210.1021/la903595x ↗
46. Jones N. A. · Biochim. Biophys. Acta, Gene Struct. Expression · 2000 · 1517 · 110.1016/S0167-4781(00)00220-7 ↗
47. Leng M. · Proc. Natl. Acad. Sci. U.S.A. · 1966 · 56 · 132510.1073/pnas.56.4.1325 ↗
48. Shapiro J. T. · Biochemistry · 1969 · 8 · 321910.1021/bi00836a014 ↗
49. Consolandi C. · Nucleosides, Nucleotides Nucleic Acids · 2002 · 21 · 56110.1081/NCN-120015069 ↗
50. Beier M. · Nucleic Acids Res. · 1999 · 27 · 197010.1093/nar/27.9.1970 ↗
51. Martin A. L. · Bioconjugate Chem. · 2008 · 19 · 237510.1021/bc800209u ↗
52. Xia T. · ACS Nano · 2008 · 2 · 8510.1021/nn700256c ↗
53. Gao J. · Cancer Biol. Ther. · 2009 · 8 · 167110.4161/cbt.8.17.9322 ↗
54. Duan Z. · Cancer Lett. (Shannon, Irel.) · 2010 · 293 · 22010.1016/j.canlet.2010.01.014 ↗
55. Putral L. N. · Mol. Pharmacol. · 2005 · 68 · 131110.1124/mol.105.014191 ↗
56. Oh Y.-K. · Adv. Drug Delivery Rev. · 2009 · 61 · 85010.1016/j.addr.2009.04.018 ↗
57. Gad A. E. · Biochim. Biophys. Acta, Biomembr. · 1982 · 690 · 12410.1016/0005-2736(82)90246-2 ↗
58. Wang C. Y. · Biochemistry · 1984 · 23 · 440910.1021/bi00314a026 ↗
59. Schaffer D. V. · Biotechnol. Bioeng. · 2000 · 67 · 59810.1002/(SICI)1097-0290(20000305)67:5<598::AID-BIT10>3.0.CO;2-G ↗